Text Size

The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2008 by Shaheed Beheshti Medical University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Shaheed Beheshti Medical University
ClinicalTrials.gov Identifier:
NCT00388778
First received: October 16, 2006
Last updated: January 22, 2008
Last verified: January 2008
History of Changes
  Purpose

The purpose of this study is to compare the safety and efficacy of twice daily subantimicrobial dose doxycycline 20mg with daily doxycycline 100mg in treatment of mild and moderate Acne.


Condition Intervention Phase
Acne
Inflammation
 Drug: Doxycycline
 Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne

Resource links provided by NLM:

MedlinePlus related topics: Acne
U.S. FDA Resources

Further study details as provided by Shaheed Beheshti Medical University:

Estimated Enrollment: 100
Study Start Date: October 2005
Estimated Study Completion Date: October 2006
  Eligibility

Ages Eligible for Study:   18 Years to 40 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Acne

Exclusion Criteria:

  • Pregnancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00388778

Contacts
Contact: Parviz Toossi, M.D. 98-21-22744392 src@sbmu.ac.ir

Locations
Iran, Islamic Republic of
Skin Research Center, Shaheed Beheshti Medical University Recruiting
Tehran, Iran, Islamic Republic of, 19899
Contact: Parviz Toossi, M.D.     98-21-22744392     src@sbmu.ac.ir    
Principal Investigator: Parviz Toossi, M.D.            
Sub-Investigator: Nahid Mohtasham, MD            
Sponsors and Collaborators
Shaheed Beheshti Medical University
Investigators
Principal Investigator: Parviz Toossi, M.D. Shaheed Beheshti Medical University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00388778     History of Changes
Other Study ID Numbers: src-pts-964
Study First Received: October 16, 2006
Last Updated: January 22, 2008
Health Authority: Iran: Ethics Committee

Additional relevant MeSH terms:
Acne Vulgaris
Inflammation
Acneiform Eruptions
Skin Diseases
Facial Dermatoses
Sebaceous Gland Diseases
Pathologic Processes
Doxycycline
 Doxycycline hyclate
Anti-Bacterial Agents
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Antimalarials
Antiprotozoal Agents
Antiparasitic Agents

ClinicalTrials.gov processed this record on June 18, 2013